These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18662076)

  • 1. [Venous thromboembolism and liver cirrhosis].
    García-Fuster MJ; Abdilla N; Fabiá MJ; Fernández C; Oliver V; Forner M J
    Rev Esp Enferm Dig; 2008 May; 100(5):259-62. PubMed ID: 18662076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism.
    Northup PG; McMahon MM; Ruhl AP; Altschuler SE; Volk-Bednarz A; Caldwell SH; Berg CL
    Am J Gastroenterol; 2006 Jul; 101(7):1524-8; quiz 1680. PubMed ID: 16863556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients.
    Yang LS; Alukaidey S; Croucher K; Dowling D
    Intern Med J; 2018 Sep; 48(9):1056-1063. PubMed ID: 29468795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding.
    Intagliata NM; Henry ZH; Shah N; Lisman T; Caldwell SH; Northup PG
    Liver Int; 2014 Jan; 34(1):26-32. PubMed ID: 23758818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in cirrhosis.
    Yang ZJ; Costa KA; Novelli EM; Smith RE
    Clin Appl Thromb Hemost; 2014 Mar; 20(2):169-78. PubMed ID: 23076776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, Risk Factors, and In-Hospital Mortality of Venous Thromboembolism in Liver Cirrhosis: A Single-Center Retrospective Observational Study.
    Zhang X; Qi X; De Stefano V; Hou F; Ning Z; Zhao J; Peng Y; Li J; Deng H; Li H; Guo X
    Med Sci Monit; 2016 Mar; 22():969-76. PubMed ID: 27009380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticoagulation in Patients with Liver Cirrhosis].
    Cheong JY
    Korean J Gastroenterol; 2017 Nov; 70(5):218-222. PubMed ID: 29161790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors analysis in 672 hospitalized patients with venous thromboembolism].
    Yan ZY; Hua BL; Ma XH; Jiang JY; Fan LK; Wang SJ; Zhu TN; Bai CM; Pan JQ; Zhao YQ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):579-82. PubMed ID: 18246810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature.
    Tufano A; Guida A; Di Minno MN; Prisco D; Cerbone AM; Di Minno G
    Semin Thromb Hemost; 2011 Apr; 37(3):267-74. PubMed ID: 21455860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic prophylaxis against venous thromboembolism in hospitalized patients with cirrhosis and associated coagulopathies.
    Koliscak L; Maynor L
    Am J Health Syst Pharm; 2012 Apr; 69(8):658-63. PubMed ID: 22472867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study.
    Wu H; Nguyen GC
    Clin Gastroenterol Hepatol; 2010 Sep; 8(9):800-5. PubMed ID: 20566312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.
    Reichert JA; Hlavinka PF; Stolzfus JC
    Pharmacotherapy; 2014 Oct; 34(10):1043-9. PubMed ID: 25052037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease.
    Dabbagh O; Oza A; Prakash S; Sunna R; Saettele TM
    Chest; 2010 May; 137(5):1145-9. PubMed ID: 20040609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation in Patients With Cirrhosis: Caught Between a Rock-Liver and a Hard Place.
    Ha NB; Regal RE
    Ann Pharmacother; 2016 May; 50(5):402-9. PubMed ID: 26861989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome.
    Li SJ; Tu YM; Zhou CS; Zhang LH; Liu ZH
    Clin Exp Nephrol; 2016 Apr; 20(2):212-7. PubMed ID: 26220221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The real value of thrombophilia markers in identifying patients at high risk of venous thromboembolism.
    Mannucci PM; Franchini M
    Expert Rev Hematol; 2014 Dec; 7(6):757-65. PubMed ID: 25231393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical factors associated with venous thromboembolism risk in patients undergoing craniotomy.
    Kimmell KT; Jahromi BS
    J Neurosurg; 2015 May; 122(5):1004-11. PubMed ID: 25495743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of venous thromboembolism in patients with primary sarcoma of bone.
    Kaiser CL; Freehan MK; Driscoll DA; Schwab JH; Bernstein KA; Lozano-Calderon SA
    Surg Oncol; 2017 Dec; 26(4):506-510. PubMed ID: 29113671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors and Associated Complications of Symptomatic Venous Thromboembolism in Patients with Craniotomy for Meningioma.
    Nunno A; Li Y; Pieters TA; Towner JE; Schmidt T; Shi M; Walter K; Li YM
    World Neurosurg; 2019 Feb; 122():e1505-e1510. PubMed ID: 30468929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.